Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate vs fenofibrate vs placebo in dyslipidemia (high TG, low HDL-C)
CTR20211983Phase 3Completed
- Sponsor
- Xinghe Corporation
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemafibrate in hypertriglyceridemia, dyslipidemia, familial hypercholesterolemia (FH), sponsored by Xinghe Corporation. Started Aug 2021; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypertriglyceridemiadyslipidemiafamilial hypercholesterolemia (FH)
Beyond the preview
Go deeper on CTR20211983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211983.